Evidence map›Paper›PMID 27154242›Full record

ReviewDrugs2016

Ongoing Pharmacological Management of Chronic Pain in Pregnancy.

Bengt Källén, Margareta Reis

Abstract readReview
PubMed Publisher
In one paragraph

Review in Drugs, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study.Canadian journal of public health = Revue canadienne de sante publique · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Rheumatologic Medication Use During Pregnancy.Obstetrics and gynecology · 2020
    Review
  8. Medication Use among Pregnant Women from the 2015 Pelotas (Brazil) Birth Cohort Study.International journal of environmental research and public health · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Pain and Depression Symptoms During the Third Trimester of Pregnancy.MCN. The American journal of maternal child nursing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Bengt KällénTornblad Institute, Lund University, Biskopsgatan 7, 223 62, Lund, Sweden. Bengt.Kallen@med.lu.se.
Margareta ReisDepartment of Medical and Health Sciences, Clinical Pharmacology, Linköping University, Linköping, Sweden.
Lund University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The article discusses possible effects of the use of analgesics during pregnancy. It summarizes the pertinent literature and reports some previously unpublished data from the Swedish Medical Birth Register. Most likely the use of analgesics does not cause spontaneous abortion. Only small malformation risk increases are seen after the use of opioids and perhaps non-steroid anti-inflammatory drug (NSAID) use. If possible, the latter should be avoided during the first trimester. If exposure has occurred there is no reason to consider an interruption of the pregnancy. Continued use of analgesics may increase the risk of preeclampsia and of preterm birth, especially valid for opioids. Use of acetylsalicylic acid (ASA) in late pregnancy should be avoided because of the risk of bleeding and (valid also for NSAIDs) premature closure of the ductus arteriosus. A small risk for neonatal abstinence syndrome may exist after the use of opioids for chronic pain, notably during the third trimester and long-lasting effects on child development can possibly occur. For a woman with chronic pain, adequate use of pain killers during pregnancy is needed. It is prudent to avoid ASA and NSAIDs towards the end of the pregnancy, while acetaminophen is an acceptable option all through pregnancy. If continued use of opioids is necessary, the associated risks are low. Triptans can be used for migraine during pregnancy. If possible sumatriptan is preferable to other triptans as data for the latter are largely lacking. Ergots are preferably avoided as not enough data are available.

Indexed as

AcetaminophenAnalgesicsAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalAspirinChronic PainFemaleHumansInfant, NewbornPregnancyPregnancy ComplicationsPrenatal Exposure Delayed EffectsRisk FactorsTryptaminesAcetaminophenAnalgesicsAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalAspirinTryptamines

Identifiers

PMID27154242
OpenAlexW2347033660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.